Below is a description of the Bridge HCV training offered in collaboration with Exchange CME

ADDICTION CENTERS

Credit: 1.0 hour inclusive of CME/CNE/CE credit provided by Purdue University.

Audience: 10-15 participants inclusive of clinical as well as non-clinical staffsocial workers, counselors, advisors, and advocates.

Agenda Topics: (Dr. Norton)
  • Understanding the need for referral and linkage to HCV care
  • The national and local epidemiologic imperative: HCV treatment as prevention within PWID populations
  • Barriers to treatment of HCV-positive PWID: addressing clinical assumptions regarding eligibility and prescribing limitations
  • Updates on clinical evidence for the feasibility and success of treating HCV-positive PWID
  • A holistic approach to harm reduction
  • Real-world integration: optimizing collaboration with HCV care specialists

HCV TREATMENT CENTERS

 Credit: This is a two-part education – each educational session is 1.0 hour (total of 2.0 hours of CME/CNE/CE credit) and scheduled about a week or two apart.

Audience:  10-15 participants inclusive of MDs, PhDs RNs, PAs, NPs, pharmacists, social workers, counselors as well as your non-clinical staff who support your patients.

 Agendas
Part 1: Keys to Successful Treatment of HCV in People Who Inject Drugs (Dr. Norton)
  • The national and local epidemiologic imperative: HCV treatment as prevention within PWID populations
  • Barriers to treatment of HCV-positive PWID: addressing clinical assumptions regarding eligibility and prescribing limitations
  • Updates on clinical evidence for the feasibility and success of treating HCV-positive PWID
  • Real-world integration: Optimizing sustained virologic response (SVR) and reinfection prevention in PWID
Part 2: Anatomy of Addiction (Includes a Harm Reduction Specialist with Dr. Norton)
  • The direct risks and clinical ramifications of injection practices
  • A holistic approach to harm reduction
  • The HCV treater’s role in overdose-death prevention
  • Educating the patient and the provider
  • Optimizing interdisciplinary collaboration in support of HCV-positive PWID

For more information, contact

Mara Simpson

Vice President, Account Services

Integritas Communications Group

Cell: 719-648-8204

msimpson@integritasgrp.com

©2019 HepFree.NYC. All rights reserved. Site by Lookit Design QuikSite®

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you. Thank you.

Sending
or

Log in with your credentials

Forgot your details?